Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

China Pediatric Pharmaceuticals Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of China Pediatric Pharmaceuticals Inc (CPDU) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of 2014
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
vs 100.00 % a year ago
Revenue Growth Y/Y
79.17 %
2014
Net Margin
-96.57 %
2014

Key Findings: China Pediatric Pharmaceuticals Inc vs Its Competitors

  • TTM: Trailing 12-month revenue of 4M vs -M combined for tracked competitors (100.0% combined share).
  • Trending: Latest-quarter revenue run-rate is accelerating (+42.9% annualized vs trailing 12 months).
  • Peer revenue share: China Pediatric Pharmaceuticals Inc accounted for 100.0% of combined revenue among its tracked peer group, up from 100.0% a year earlier.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

CPDU Sales vs. its Competitors, 2014

China Pediatric Pharmaceuticals Inc generated 100.00 % of the combined sales of its peer group, up from 100.00 % a year earlier.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/CPDU/competitors
https://api.csimarket.com/api/v1/companies/CPDU/relationships
https://api.csimarket.com/api/v1/companies/CPDU/similar
Programmatic access for models, analytics, and integration workflows.

For context: the Healthcare Facilities industry grew revenue 14.8% year over year, combined, vs 79.2% for China Pediatric Pharmaceuticals Inc. China Pediatric Pharmaceuticals Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.

China Pediatric Pharmaceuticals Inc's Competitor Quality Breadth

Share of each group, trailing 12 months: profitable (net margin > 0), expanding (revenue growth > 0), growing faster than the industry's own median, and financially distressed (Piotroski F-Score of 2 or below).

Entity Profitable Expanding Above Industry Growth Distressed
China Pediatric Pharmaceuticals, Inc. Yes No No No
Similar Growth & Profitability (8) 62.50 % (5 of 8) 0.00 % (0 of 8) 0.00 % (0 of 8) 0.00 % (0 of 8)

Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.

Market Share of the Peer Group, 2014

100%market share
  • China Pediatric Pharmaceuticals Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of China Pediatric Pharmaceuticals Inc and its 0 tracked competitors.

See China Pediatric Pharmaceuticals Inc's full market share breakdown »

CPDU Stock Performance relative to its Competitors

CPDU Competitors (weighted) Percent change over the selected range

CPDU Stock Performance relative to Similar Growth & Profitability Competitors

CPDU Similar Growth & Profitability Competitors (equal-weighted, 8) Percent change over the selected range
Get the full CSIMarket dataset: Subscribe API Connect Your AI